Gene expression changes in initiation and progression of oral squamous cell carcinomas revealed by laser microdissection and oligonucleotide microarray analysis

International Journal of Cancer

Volumn 132, Issue 3, 2013, Pages 540-548

  Sumino, Jun ^a   Uzawa, Narikazu ^a   Okada, Norihiko ^a   Miyaguchi, Ken ^a   Mogushi, Kaoru ^a   Takahashi, Ken Ichiro ^a   Sato, Hiroaki ^a   Michikawa, Chieko ^a   Nakata, Yoshimi ^a   Tanaka, Hiroshi ^a   Amagasa, Teruo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

carcinogenesis; ISG15; laser microdissection; microarray; oral; squamous cell carcinoma

Indexed keywords

APOLIPOPROTEIN C1; CELL PROTEIN; PROTEIN ISG15; UNCLASSIFIED DRUG;

ACTG2 GENE; ADULT; APOC1 GENE; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CARCINOGENESIS; CONTROLLED STUDY; DNA MICROARRAY; FAM149A GENE; FCGR3A GENE; FEMALE; FMO1 GENE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; ISG15 GENE; LASER MICRODISSECTION; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; MOUTH SQUAMOUS CELL CARCINOMA; NRIP2 GENE; NUCB2 GENE; NUCLEOTIDE SEQUENCE; OMA1 GENE; ORAL DYSPLASTIC LESION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PZP GENE; RAPGEF6 GENE; SLC29A3 GENE; STMN3 GENE; SURVIVAL RATE; SYT10 GENE; TMPRSS11B GENE;

CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LASER CAPTURE MICRODISSECTION; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UBIQUITINS;

EID: 84870250550     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27702     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Méndez E, Cheng C, Farwell DG, et al. Transcriptional expression profiles of oral squamous cell carcinomas. Cancer 2002; 95: 1482-94.
3. van der Waal I,. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol 2010; 46: 423-5.
4. Kramer IR, Lucas RB, Pindborg JJ, et al. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978; 46: 518-39.
5. Amagasa T, Yamashiro M, Uzawa N,. Oral premalignant lesions: from a clinical perspective. Int J Clin Oncol 2011; 16: 5-14.
6. Nankivell P, Mehanna H,. Oral dysplasia: biomarkers, treatment, and follow-up. Curr Oncol Rep 2011; 13: 145-52.
7. Ha PK, Benoit NE, Yochem R, et al. A transcriptional progression model for head and neck cancer. Clin Cancer Res 2003; 9: 3058-64.
8. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996; 56: 2488-92.
9. Irié T, Aida T, Tachikawa T,. Gene expression profiling of oral squamous cell carcinoma using laser microdissection and cDNA microarray. Med Electron Microsc 2004; 37: 89-96.
10. Choi P, Chen C,. Genetic expression profiles and biologic pathway alternation in head and neck squamous cell carcinoma. Cancer 2005; 104: 1113-28.
11. Simone NL, Bonner RF, Gillespie JW, et al. Laser-capture microdissection: opening the microscopic frontier to molecular analysis. Trends Genet 1998; 14: 272-6.
12. Jakobsson PA, Eneroth CM, Killander D, et al. Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol Ther Phys Biol 1973; 12: 1-8.
13. Yamamoto E, Kohama G, Sunakawa H, et al. Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity. Cancer 1983; 51: 2175-80.
14. Bektas N, Noetzel E, Veeck J, et al. The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer. Breast Cancer Res 2008; 10: R58.
15. Oue N, Hamai Y, Mitani Y, et al. Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 2004; 64: 2397-405.
16. Begum A, Imoto I, Kozaki K, et al. Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma. Cancer Sci 2009; 100: 1908-16.
17. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8.
18. Chi LM, Lee CW, Chang KP, et al. Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS. Mol Cell Proteomics 2009; 8: 1453-74.
19. Ye H, Yu T, Temam S, et al. Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics 2008; 9: 69.
20. Andersen JB, Aaboe M, Borden EC, et al. Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer. Br J Cancer 2006; 94: 1465-71.
21. Desai SD, Haas AL, Wood LM, et al. Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res 2006; 66: 921-8.
22. Desai SD, Reed RE, Burks J, et al. ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells. Exp Biol Med 2012; 237: 38-49.
23. Bani MR, Nicoletti MI, Alkharouf NW, et al. Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts. Mol Cancer Ther 2004; 3: 111-21.
24. Matsumura Y, Yashiro M, Ohira M, et al. 5-Fluorouracil up-regulates interferon pathway gene expression in esophageal cancer cells. Anticancer Res 2005; 25: 3271-8.
25. Smith J, Rattay T, McConkey C, et al. Biomarkers in dysplasia of the oral cavity: a systematic review. Oral Oncol 2009; 45: 647-53.